Richard Edlin

Uncertainty, Probabilistic Analysis and Outputs from Cost Effectiveness Analyses

Peter Hall, Christopher McCabe, Richard Edlin, 2015 .

Finding the Evidence for Decision Analytic Cost Effectiveness Models

Peter Hall, Christopher McCabe, Richard Edlin, 2015 .

Cost Effectiveness Modelling for Health Technology Assessment

Christopher McCabe, Richard Edlin, Judy Wright, 2015 .

Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?

Christopher McCabe, Richard Edlin, Klemens Wallner, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?

Richard Edlin, Paul Dolan, P. Dolan, 2002, Journal of health economics.

Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?

Christopher McCabe, Richard Edlin, R. Edlin, 2013, PharmacoEconomics.

The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer

Richard Edlin, Ross Lawrenson, Peter Gilling, 2017, BMC Cancer.

An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer

Ivana Holloway, Christopher McCabe, Phil Quirke, 2012, International Journal of Colorectal Disease.

It ain?t what you do, it's the way that you do it: Characteristics of procedural justice and their importance in social decision-making

Aki Tsuchiya, Allan Wailoo, Richard Edlin, 2007 .